Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)
Condition(s):Clostridium Difficile Infection (CDI)Last Updated:June 10, 2022Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Clostridium Difficile Infection (CDI)Last Updated:June 10, 2022Enrolling by invitation
Condition(s):Clostridium Difficile Infection (CDI)Last Updated:December 16, 2022Recruiting
Condition(s):Clostridium Difficile InfectionLast Updated:August 11, 2020Completed
Condition(s):Clostridium Difficile InfectionLast Updated:October 12, 2017Completed
Condition(s):Clostridium Difficile Infection; Clostridium Difficile DiarrheaLast Updated:March 15, 2018Unknown status
Condition(s):Clostridium Difficile InfectionLast Updated:October 17, 2016Completed
Condition(s):Clostridium Difficile InfectionLast Updated:December 15, 2021Terminated
Condition(s):Clostridium Difficile InfectionLast Updated:August 14, 2023Completed
Condition(s):Clostridium Difficile InfectionLast Updated:December 30, 2014Completed
Condition(s):Clostridium Difficile InfectionLast Updated:February 9, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.